We confirmed MLH1 promoter hypermethylation in endometrial cancer tissue samples and suspected epigenetic silencing of MLH1. However, because of the early age of onset of endometrial cancer and presence of family history of Lynch-related malignancies, we suspected her of showing Lynch syndrome; therefore, we offered her genetic counseling. This evidence concerns the gene MLH1 and Lynch syndrome.